Urinary Tract Infection AND Complicated UTI Pyelonephritis

The answer first

Urinary tract infection is among the commonest reasons for antibiotics in adults, and the physician's job is not simply to prescribe, but to distinguish uncomplicated cystitis from a complicated infection that needs imaging, intravenous therapy or source control. The 2010 IDSA guideline on acute cystitis and pyelonephritis, the 2019 asymptomatic bacteriuria update, and the catheter-UTI guideline frame practice: choose narrow-spectrum first-line therapy for uncomplicated cystitis (nitrofurantoin or trimethoprim-sulfamethoxazole), reserve fluoroquinolones for pyelonephritis and prostatitis, do not treat asymptomatic bacteriuria except in pregnancy or before urological instrumentation, and remove unnecessary catheters. [1] [3]

A defensible exam answer rests on four pillars: [1]

1. Define the syndrome and the host. Uncomplicated UTI is acute cystitis or pyelonephritis in a non-pregnant, premenopausal woman with no anatomical or functional abnormality. Everything else — men, pregnancy, diabetes, obstruction, catheter, immunocompromise, recent instrumentation, healthcare-associated, resistant organism, renal failure, stones — is complicated and changes both empiric choice and duration. [1]
2. Confirm the diagnosis before treating, when feasible. Symptoms plus pyuria (leukocyte esterase or microscopy) are sufficient for uncomplicated cystitis in a woman; obtain urine culture for pyelonephritis, complicated UTI, recurrent UTI, pregnancy, atypical organisms, and treatment failure. Do not treat asymptomatic bacteriuria — it increases antibiotic exposure without benefit, except in pregnancy or before urological procedures. [3]
3. Choose the narrowest effective agent for the shortest effective duration. Uncomplicated cystitis: nitrofurantoin 100 mg twice daily for five days or trimethoprim-sulfamethoxazole 160/800 mg twice daily for three days (where local Escherichia coli resistance is under 20 percent). Uncomplicated pyelonephritis: oral ciprofloxacin 500 mg twice daily for seven days or co-amoxiclav for ten to fourteen days; IV ceftriaxone 1 to 2 g daily until afebrile, then oral step-down. The Sandberg trial established that seven days of ciprofloxacin is non-inferior to 14 days in acute pyelonephritis. [4]
4. Identify and manage the surgical and resistant-organism emergencies. Emphysematous pyelonephritis (gas in renal tissue on CT in a diabetic patient), pyonephrosis (obstructed infected system), xanthogranulomatous pyelonephritis (chronic destruction with a renal mass), and infection with extended-spectrum beta-lactamase producers each demand a specific pathway — imaging, source control, broad empiric cover, and early urological or infectious-diseases referral. [7] [8]

DWE high-yield: "Do not treat the asymptomatic culture." Asymptomatic bacteriuria is common in older adults, catheterised patients and diabetics, and treatment increases antibiotic exposure, resistance and adverse events without clinical benefit. Treat only in pregnancy, before transurethral prostate resection or other urological instrumentation where mucosal bleeding is expected, and possibly in neutropenia or recent renal transplant — and no other group. [3]

References12Show ledgerHide ledger

1. [1]Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases Clin Infect Dis, 2011.PMID 21292654
2. [2]Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America Clin Infect Dis, 2010.PMID 20175247
3. [3]Nicolle LE, Gupta K, Bradley SF, et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America Clin Infect Dis, 2019.PMID 30895288
4. [4]Sandberg T, Skoog G, Hermansson AB, et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial Lancet, 2012.PMID 22726802
5. [5]Lipsky BA, Byren I, Hoey CT Treatment of bacterial prostatitis Clin Infect Dis, 2010.PMID 20459324
6. [6]Smaill FM, Vazquez JC Antibiotics for asymptomatic bacteriuria in pregnancy Cochrane Database Syst Rev, 2019.PMID 31765489
7. [7]Huang JJ, Tseng CC Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis Arch Intern Med, 2000.PMID 10737279
8. [8]Gravestock P, Moore L, Harding C, et al. Xanthogranulomatous pyelonephritis: a review and meta-analysis with a focus on management Int Urol Nephrol, 2022.PMID 35809205
9. [9]Pasternak B, Inghammar M, Svanström H Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study BMJ, 2018.PMID 29519881
10. [10]Patel PK, Advani SD, Kofman AD, et al. Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 Update Infect Control Hosp Epidemiol, 2023.PMID 37620117
11. [11]Ubee SS, McGlynn L, Fordham M Emphysematous pyelonephritis BJU Int, 2011.PMID 20840327
12. [12]Meddings J, Rogers MA, Krein SL, et al. Reducing unnecessary urinary catheter use and other strategies to prevent catheter-associated urinary tract infection: an integrative review BMJ Qual Saf, 2014.PMID 24077850